JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 2, 2006; DOI: 10.1124/jpet.106.105098


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.105098v1
318/2/828    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Hashida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, Y.
Right arrow Articles by Hashida, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication March 24, 2006.
Revised April 27, 2006.
Accepted for publication April 28, 2006.

Efficient Gene Transfer into Macrophages and Dendritic Cells by in Vivo Gene Delivery with Mannosylated Lipoplex via the Intraperitoneal Route

Yoshiyuki Hattori 1, Shigeru Kawakami 1, Kazumi Nakamura 1, Fumiyoshi Yamashita 1, Mitsuru Hashida 1*

1 Kyoto University

* Address correspondence to: E-mail: hashidam{at}pharm.kyoto-u.ac.jp

Abstract

In this study, we developed an antigen presenting cells (APCs) selective intraperitoneal gene delivery system with mannosylated cationic liposomes (Man- liposomes)/plasmid DNA complex (Man-lipoplex). An in vitro study using cultured peritoneal macrophages demonstrated that Man-liposomes could transfect luciferase-encoding plasmid DNA (pCMV-Luc) more efficiently than cationic liposomes via a mannose receptor-mediated mechanism. In vivo gene transfection studies revealed that Man-lipoplex showed a higher gene expression in the liver, spleen, peritoneal exuded cells, and mesenteric lymph nodes than lipoplex or naked pCMV-Luc after intraperitoneal administration and this gene expression lasted for at least 24 h. The transfection activity of Man-lipoplex after intraperitoneal administration was significantly higher than that after intravenous gene delivery with the Man-liposomes we developed previously, indicating that gene delivery via the intraperitoneal route seems to be an efficient approach for in vivo gene delivery to APCs. Furthermore, it was demonstrated that Man-lipoplex could enhance gene expression in both F4/80+ and CD11c+ cells in the spleen. These results show that gene delivery with Man-liposomes via the intraperitoneal route could be an effective approach for APC-selective gene transfection.


Key words: DNA vaccine, Dendritic cells, Drug delivery system, Gene delivery, Non-viral vectors, Targeting





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.